Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.

Research communications in molecular pathology and pharmacology - 1 Jan 2003

Tigli Hulya, Yazici Hulya, Dalay Nejat

Abstract excerpt

Steroid hormones, especially androgens, are believed to play a key role in the etiology of prostate cancer. Therefore, polymorphisms in genes involved in the androgen metabolism may affect the risk of prostate cancer. One such gene is CYP17, which encodes the cytochrome P450c17alpha enzyme that m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies
Share to Polymorphism, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prevalence

Share to Prostatic Hyperplasia

Share to Prostatic Neoplasms

Share to Steroid 17-alpha-Hydroxylase

Share to Turkey

Source

Identifiers

PMID: 15686129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15686129-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.PMID 15686129Read ↗

Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.Semantic proximity Read ↗

Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.Semantic proximity Read ↗

Relationship between CYP17 gene polymorphisms and risk of prostate cancer.Semantic proximity Read ↗

CYP17 gene polymorphism and its association in north Indian prostate cancer patients.Semantic proximity Read ↗

Prostate cancer associated with CYP17 genotype.Semantic proximity Read ↗

Genetic polymorphism in sex hormone metabolism and prostate cancer risk.Semantic proximity Read ↗

A polymorphism in the CYP17 gene is associated with prostate cancer risk.Semantic proximity Read ↗

The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk.Semantic proximity Read ↗

CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.